# Bitcoin is the Gateway Drug

**Published by:** [PsyDAO](https://paragraph.com/@psydao-2/)
**Published on:** 2024-11-29
**URL:** https://paragraph.com/@psydao-2/bitcoin-is-the-gateway-drug

## Content

[Written by Steven Fülle] Before Bitcoin powered trillion dollar financial markets, it powered the psychedelic renaissance. The Silk Road marketplace, launched in 2011, became cryptocurrency's first major use case. By anonymously connecting buyers and sellers through Bitcoin, the Silk Road became the Amazon for all things taboo - including psychedelics. Before its dramatic shutdown in 2013 and the incarceration of its founder Ross Ulbricht, the notorious marketplace processed $1.2 billion in transactions and left a lasting impact on both the cryptocurrency scene and psychedelic culture. But the connection between psychedelics and cryptocurrency runs far deeper than a digital black market. The cypherpunk movement—which ultimately gave birth to Bitcoin—emerged directly from the same countercultural soil as the psychedelic revolution. Both movements shared the fundamental vision of fostering individual autonomy and challenging traditional systems of control by utilizing tools, whether technological or chemical, to empower individuals to explore new dimensions of freedom and consciousness. The infamous prophet of psychedelics, Timothy Leary, recognized this parallel early on when he declared that "computers are the new LSD." Today, this historical alliance between psychedelics and crypto technology is experiencing a renaissance of its own. From memes claiming that Satoshi smoked DMT to rumors about ayahuasca-spiked Soylent at Ethereum meetups, today's crypto culture pulses with psychedelic energy. But the true fusion of these worlds is happening in science itself, where a movement called Decentralized Science (DeSci) is revolutionizing how research is funded, conducted, and shared. To explore these possibilities, PsyDAO recently partnered with the Psychedelic Society Maastricht to facilitate a groundbreaking series of talks on DeSci's potential to transform psychedelic research. The series brought together experts from across the field to envision a future where scientific collaboration transcends traditional boundaries—tackling everything from funding mechanisms to citizen participation in research.The Promise of Decentralized ScienceIn our first session, Dr. Lukas Weidener, a medical doctor turned blockchain innovator, provided a comprehensive introduction to Decentralized Science (DeSci). As a co-author of a foundational paper on DeSci, his insights helped frame how this movement is reimagining scientific research.Current Challenges in Traditional ScienceLukas highlighted several critical issues facing modern scientific research:Access Barriers: Many scientific publications remain behind paywalls, limiting global access to knowledgeReproducibility Crisis: Current systems don't incentivize the reproduction of studies, leading to challenges in validating researchThe "Valley of Death": A critical funding gap exists between early discovery and clinical trials, particularly in biomedical researchLimited Participation: Traditional science often restricts participation to those with formal credentialsFollow PsyDAO on Twitter/X.From Open Science to DeSciLukas emphasized that DeSci isn't emerging in isolation, but rather building upon and extending the established open science movement. Open science has long advocated for:Making publications freely accessible to everyoneOpening access to research dataRemoving institutional barriers to scientific knowledgePromoting transparency in research methodsDeSci can be understood as the next evolutionary step where:Technology Enables Implementation: Rather than just advocating for openness, blockchain technology provides the infrastructure to ensure itIncentives Are Built-In: Unlike traditional open science initiatives, DeSci incorporates token-based incentives for sharing and collaborationGovernance Is Decentralized: Instead of relying on institutional goodwill, decision-making power is distributed through Decentralized Autonomous Organizations (DAOs)Participation Is Permissionless: Beyond just access to read papers, DeSci enables anyone to actively participate in the scientific processWhile blockchain technology enables DeSci's evolution beyond open science, what truly sets the movement apart is its fundamental values. Lukas emphasized that DeSci is, at its core, a value-based movement that reimagines not just how we do science, but who gets to participate and how they're incentivized to contribute.PsyDAO: Decentralized Psychedelic ScienceThe story of PsyDAO began with one of its founders, Jesse, whose journey took him from the pioneering pages of Erowid to the Amazon rainforest and ultimately to the forefront of technology. His unique background as an anthropologist and lawyer, combined with a deep respect for indigenous wisdom and his role at the decentralized science infrastructure provider Molecule, helped shape the vision that would become PsyDAO. You can listen to his psychedelic origin story here: The challenges of Psychedelic SciencePsyDAO emerged from a recognition that the traditional funding model for psychedelic research faces several critical challenges:Clinical Trial Bottlenecks: Traditional psychedelic clinical trials struggle with both participant recruitment and diversity issues, limiting the scope and applicability of research findings.IP Ethics Crisis: The psychedelic patent landscape has become what Jesse describes as "a warzone with an ethical minefield," with increasing concerns about monopolistic practices and ethical IP rights.Indigenous Knowledge Gap: Despite being the original stewards of psychedelic knowledge, psychedelic-endogenous indigenous tribes remain impoverished and often excluded from the benefits of modern research and commercialization.Learn more about PsyDAO’s new Autonomous Research Discovery System BeeARD.How PsyDAO WorksPsyDAO addresses these challenges through several innovative mechanisms: Community-Driven Governance PsyDAO's dual-token system ensures ethical oversight and community participation:Core members (PSYC holders) provide strategic direction and ethical oversightBroader community (PSY holders) participates in funding and research decisionsTransparent decision-making processBuilt-in mechanisms for sustainable growth and developmentIP Tokenization Framework One of PsyDAO's most innovative contributions is their implementation of tokenized IP through IP-NFTs (Intellectual Property Non-Fungible Tokens) and fungible IPTs (IP tokens). This framework:Allows for fractional ownership and governance of research IPCreates transparent revenue sharing mechanismsEnables community funding while preserving researcher incentivesProtects rights through smart contractsIndigenous Wisdom Integration PsyDAO has developed unique frameworks to bridge traditional knowledge with modern science:Direct partnerships with indigenous communities like the Shipibo-ConiboFair compensation through built-in royalty systemsPreservation and protection of traditional knowledgeThe Dawn of Decentralized DiscoveryPsyDAO is moving from vision to implementation through several key initiatives:BeeARD: A swarm of AI research assistants functioning like tireless PhD candidates, continuously analyzing new research papers and identifying promising areas for new scientific researchOPSY (Open Psychedelic Science ecosYstem): A web3-native platform bridging clinical trials and naturalistic experiences through:Token-incentivized participationUser data sovereigntyCreation of a collectively owned knowledge libraryResearch Facilities: Development of centers in St. Vincent, where psychedelics are legal for medical useFunding: With about $2 million in Ethereum raised, PsyDAO is now actively funding psychedelic scienceResearchers and PhD candidates of all disciplines are encouraged to submit their proposals and contribute to decentralized psychedelic science. If there are any other ways you’d like to contribute to PsyDAO, feel free to connect with us on Discord.DeSci in Action: The Future of Citizen ScienceAleksandra Wingert, a PhD candidate at the Center for Psychedelic Research at Imperial College London, presented her work on the Microdosing 2.0 trial, which exemplifies DeSci principles in practice. Building upon Balázs Szigeti's pioneering self-blinding study, this project demonstrates how decentralized approaches can transform psychedelic research from an exclusive academic pursuit into a community-driven scientific endeavor.Democratizing Research Through Citizen ScienceCitizen science refers to research conducted by regular people who step into researchers' shoes without necessarily having formal scientific training or credentials. In psychedelic research, this approach offers several key advantages:Cost-effective way to collect large-scale, real-world dataEnables participation from diverse populationsBridges the gap between controlled trials and naturalistic useCreates opportunities for broader community involvementWhile this approach presents challenges in controlling variables and standardizing procedures, the Microdosing 2.0 study demonstrates how rigorous methodology can be applied to citizen science research.The Self-Blinding Protocol: Where Scientific Rigor meets DeSciThe Microdosing 2.0 study investigates the effects of psychedelic microdosing on people with mood problems through a unique self-blinding protocol. Unlike traditional clinical trials where researchers provide substances, participants use their own materials and follow a structured protocol:Participants prepare their own microdose and placebo capsulesQR codes enable reliable self-blinding, ensuring participants don't know which days they take active dosesHome testing kits verify substance content and quantity, ensuring research qualityA combination of online questionnaires and laboratory measures tracks outcomesThis innovative approach enables the study of real-world microdosing while maintaining scientific rigor through careful measurement and controlled conditions.Beyond Self-ReportsWhile traditional citizen science often relies solely on participant questionnaires, the Microdosing 2.0 study incorporates laboratory measurements to provide objective data. This combination of subjective experiences and biological markers offers a more complete picture of microdosing effects:EEG measurements of brain connectivityBlood samples for BDNF levels and immune responseSleep and heart rate monitoringSpecial focus on female health markers, including menopause and hormonal effectsBy incorporating these rigorous measurements, the study aims to validate (or challenge) anecdotal reports with hard scientific data while maintaining the advantages of real-world research settings.Beyond the Gateway: A New Scientific FrontierThis three-part series has taken us from the theoretical framework of decentralized science, through PsyDAO's practical implementation, to hands-on citizen science. The Microdosing 2.0 study demonstrates how research can become more accessible while maintaining scientific rigor. It only seems natural that future projects like this will be supported by the DeSci infrastructure that PsyDAO is building. With platforms for open science psychedelic research like OPSY on the horizon and an engaged community ready to contribute, it becomes obvious that the historic alliance between psychonauts and cypherpunks has come full circle. What began as a shared vision of individual freedom has evolved into something far more powerful: a revolution in how humanity explores consciousness and reality itself.

## Publication Information

- [PsyDAO](https://paragraph.com/@psydao-2/): Publication homepage
- [All Posts](https://paragraph.com/@psydao-2/): More posts from this publication
- [RSS Feed](https://api.paragraph.com/blogs/rss/@psydao-2): Subscribe to updates
- [Twitter](https://twitter.com/psy_dao): Follow on Twitter